“HIGH-COST MEDICATIONS IN THE SUS: COPD PATIENTS IN A VULNERABLE STATE”. Editora Impacto Científico (September 23, 2025): 211–219. Accessed February 7, 2026. https://periodicos.newsciencepubl.com/editoraimpacto/article/view/8344.